Related Experiment Video
Updated: Jul 19, 2026

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
Published on: November 23, 2017
Plasminogen activator inhibitor-1 impairs plasminogen activation-mediated vascular smooth muscle cell apoptosis
Patrick Rossignol1, Eduardo Anglès-Cano, Henri Roger Lijnen
1Center for Molecular and Vascular Biology, K.U.Leuven, Leuven, Belgium.
Abstract:
The role of plasminogen activator inhibitor-1 (PAI-1) in vascular smooth muscle cell (VSMC) apoptosis mediated by plasminogen activation was studied with the use of aorticVSMC derived from mice with deficiency of PAI-1 (PAI-1 (-/-) ), tissue-type (t-PA (-/-) ) or urokinase-type (u-PA (-/-) ) plasminogen activator or from wildtype (WT) mice with corresponding genetic background. Plasminogen incubated with confluent VSMC was activated in a concentration-dependent and saturable manner for all four cell types, with maximal activation rates that were comparable for WT, u-PA (-/-) and t-PA (-/-) cells, but about two-fold higher for PAI-1 (-/-) cells. Plasminogen activation was impaired by addition of the lysine analogue 6-aminohexanoic acid, and by addition of t-PA and u-PA neutralizing antibodies, suggesting that it depends on binding to cell surface COOH-terminal lysine residues, and on plasminogen activator activity. Morphological alterations consistent with apoptosis were observed much earlier in PAI-1 (-/-) than in WT VSMC. Without addition of plasminogen, the apoptotic index was similar for all four cell types, whereas after incubation with physiological plasminogen concentrations, it was greater in PAI-1 (-/-) VSMC, as compared to WT, t-PA (-/-) or u-PA (-/-) VSMC. Furthermore, the apoptotic rate paralleled the release of plasmin. Thus, plasmin-mediated apoptosis of VSMC occurs via plasminogen activation by either t-PA or u-PA and is impaired by PAI-1.
Insights
Plasminogen activator inhibitor-1 (PAI-1) impairs plasmin-mediated apoptosis in vascular smooth muscle cells (VSMCs). Reducing PAI-1 accelerates VSMC apoptosis via plasminogen activation by tissue-type (t-PA) or urokinase-type (u-PA) plasminogen activators.
Area of Science:
- Molecular Biology
- Cell Biology
- Cardiovascular Research
Background:
- Vascular smooth muscle cell (VSMC) apoptosis plays a critical role in cardiovascular diseases.
- Plasminogen activation system components, including plasminogen activator inhibitor-1 (PAI-1), are implicated in VSMC biology.
- The precise role of PAI-1 in VSMC apoptosis mediated by plasminogen activation remains to be fully elucidated.
Purpose of the Study:
- To investigate the role of plasminogen activator inhibitor-1 (PAI-1) in vascular smooth muscle cell (VSMC) apoptosis.
- To determine how PAI-1 influences plasminogen activation and subsequent apoptotic processes in VSMCs.
- To compare apoptosis rates in VSMCs with and without PAI-1, and with deficiencies in tissue-type (t-PA) or urokinase-type (u-PA) plasminogen activators.
Main Methods:
- Utilized aortic VSMCs from PAI-1 deficient (PAI-1 (-/-)), t-PA deficient (t-PA (-/-)), u-PA deficient (u-PA (-/-)), and wildtype (WT) mice.
- Assessed plasminogen activation rates on VSMC surfaces.
- Quantified VSMC apoptosis using morphological analysis and apoptotic index measurements after incubation with plasminogen.
Main Results:
- Plasminogen activation on VSMCs was concentration-dependent and saturable, with higher rates observed in PAI-1 (-/-) cells compared to WT, t-PA (-/-), or u-PA (-/-) cells.
- Plasminogen activation was dependent on cell surface COOH-terminal lysine residues and plasminogen activator activity.
- PAI-1 (-/-) VSMCs exhibited significantly earlier and higher rates of apoptosis when incubated with plasminogen, correlating with plasmin release.
Conclusions:
- Plasmin-mediated apoptosis of VSMCs occurs through plasminogen activation by either t-PA or u-PA.
- Plasminogen activator inhibitor-1 (PAI-1) significantly impairs plasmin-mediated VSMC apoptosis.
- These findings highlight PAI-1 as a key regulator of VSMC apoptosis in the context of plasminogen activation.
Related Concept Videos
Clot Retraction and Fibrinolysis
Vascular Spasm
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Atherosclerosis I: Introduction
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Intracellular Signaling Affects Focal Adhesions
Some...

